Hepatocellular carcinoma (HCC) remains not only a cause of a considerable part of
oncologic mortality, but also a diagnostic and therapeutic challenge for healthcare systems …

Objective Hepatocellular carcinoma (HCC) often develops in patients with alcohol-related
cirrhosis at an annual risk of up to 2.5%. Some host genetic risk factors have been identified …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with high
morbidity and mortality, which seriously threatens the health and life expectancy of patients …

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is associated
with high mortality rates. Approximately 80% of cases occur in cirrhotic livers, posing a …

Abstract Purpose of Review Cirrhosis is a highly prevalent condition with significant
economic and overall burden to patients, caregivers, and the health systems. It is most …

Introduction: While combination of stereotactic body radiotherapy (SBRT) and
immunotherapy are promising, their efficacy and safety have not been compared with SBRT …

Simple Summary This retrospective study focused on 23 patients diagnosed with
Hepatocellular Carcinoma (HCC), utilizing the Liver Imaging Reporting and Data System (LI …

Purpose Locoregional therapies (LRT) are employed for bridging patients with
hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT). Although …

Background and Objectives: In the early period after liver transplantation, patients are
exposed to a high rate of complications and several scores are currently available to predict …

Simple Summary Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer that
arises in a background of chronic hepatic injury. Metabolic syndrome-associated fatty liver …